Rachel Vatnsdal Stock Analyst Profile - JP Morgan Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rachel Vatnsdal

    Stock Analyst at JP Morgan

    (4.64)
    # 1409
    Out of 5,477 analysts
    71
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare Basic Materials
    Top Industries:
    Medical - Diagnostics & Research Medical - Instruments & Supplies Medical - Healthcare Information Services
    23 Stocks
    Name Action PT Current % Upside Ratings Updated
    HSIC Henry Schein
    Maintains: Overweight
    80 76
    		69.55 9.27% 4 Aug 7, 2025
    ADPT Adaptive Biotechnolo...
    Maintains: Overweight
    10 14
    		13.49 3.78% 5 Aug 6, 2025
    AVTR Avantor
    Maintains: Overweight
    17 14
    		13.02 7.53% 1 Aug 4, 2025
    CAI Caris Life Sciences
    Initiates Coverage On: Overweight
    31
    		34.21 -9.38% 1 Jul 14, 2025
    TXG 10x Genomics
    Maintains: Neutral
    12 9
    		13.06 -31.09% 4 May 9, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Underweight
    40 33
    		25.61 28.86% 2 May 6, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    200 190
    		119.51 58.98% 6 Apr 29, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    120 100
    		85.62 16.8% 4 Apr 29, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    20 19
    		21.61 -12.08% 4 Mar 6, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    380 390
    		302.46 28.94% 4 Mar 6, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    50 55
    		88.84 -38.09% 3 Feb 25, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    50 55
    		56.8 -3.17% 1 Feb 21, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    165 160
    		n/a n/a 6 Nov 26, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    650 670
    		491.2 36.4% 8 Sep 20, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Underweight
    17 20
    		7.68 160.42% 3 Aug 7, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 2 Aug 6, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    1300 1400
    		1281.62 9.24% 2 Aug 5, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 1 Apr 22, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Overweight
    60 90
    		32.07 180.64% 2 Feb 14, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    250 270
    		195.17 38.34% 4 Dec 20, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 1 Nov 27, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    90 45
    		63.48 -29.11% 1 May 22, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Underweight
    n/a
    		n/a n/a 2 Nov 10, 2022